The Impact of Midlife on Migraine in Women: Summary of Current Views

Overview

Journal Womens Midlife Health

Publisher Biomed Central

Date 2020 Oct 12

PMID 33042563

Citations 4

Authors

Jelena M Pavlovic

Affiliations

Soon will be listed here.

Abstract

Migraine is three times more common in women than in men and is the 4th leading cause of disability in women. Onset of migraine increases at menarche, with peaks in prevalence in the late 30s, and a rapid decline after menopause. While the prevalence is highest among women of childbearing age the frequency of headache and burden of migraine frequently worsens during midlife. Abundant population data suggest that hormonal factors may trigger headache attacks and influence onset and remission. The midlife worsening of migraine is attributed to hormonal fluctuations characteristic of the menopausal transition. Drops in estrogen presumably lead to increased migraine attacks at the time of menses as well as during the menopausal transition. During the menopausal transition, recommended approaches include both acute and preventive non-hormonal and hormonal options as well as behavioral approaches. Herein, is a brief review on the presentation of migraine in women across the lifespan, with special emphasis on midlife and the menopausal transition and implications for treatment.

Citing Articles

Headache and Gene Variants in Patients with CADASIL.

Szymanowicz O, Korczowska-Lacka I, Slowikowski B, Wiszniewska M, Piotrowska A, Goutor U Neurol Int. 2023; 15(4):1238-1252.

PMID: 37873835 PMC: 10594416. DOI: 10.3390/neurolint15040078.

Pain in midlife women: a growing problem in need of further research.

Pavlovic J, Derby C Womens Midlife Health. 2022; 8(1):4.

PMID: 35509086 PMC: 9068256. DOI: 10.1186/s40695-022-00074-x.

Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study.

MaassenVanDenBrink A, Terwindt G, Cohen J, Barash S, Ramirez Campos V, Galic M J Headache Pain. 2021; 22(1):152.

PMID: 34922436 PMC: 8903667. DOI: 10.1186/s10194-021-01336-1.

Urinary Proteomics Reveals Promising Biomarkers in Menstrually Related and Post-Menopause Migraine.

Bellei E, Bergamini S, Rustichelli C, Monari E, Dal Porto M, Fiorini A J Clin Med. 2021; 10(9).

PMID: 33923220 PMC: 8123166. DOI: 10.3390/jcm10091854.

References

Burch R, Buse D, Lipton R . Migraine: Epidemiology, Burden, and Comorbidity. Neurol Clin. 2019; 37(4):631-649. DOI: 10.1016/j.ncl.2019.06.001. View

Haut S, Bigal M, Lipton R . Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol. 2006; 5(2):148-157. PMC: 1457022. DOI: 10.1016/S1474-4422(06)70348-9. View

Lipton R, Stewart W, Celentano D, Reed M . Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis. Arch Intern Med. 1992; 152(6):1273-8. DOI: 10.1001/archinte.152.6.1273. View

Burch R, Loder S, Loder E, Smitherman T . The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache. 2015; 55(1):21-34. DOI: 10.1111/head.12482. View

Maleki N, Cheng Y, Tu Y, Locascio J . Longitudinal course of vasomotor symptoms in perimenopausal migraineurs. Ann Neurol. 2019; 85(6):865-874. DOI: 10.1002/ana.25476. View

Martin V, Wernke S, Mandell K, Ramadan N, Kao L, Bean J . Defining the relationship between ovarian hormones and migraine headache. Headache. 2005; 45(9):1190-201. DOI: 10.1111/j.1526-4610.2005.00242.x. View

Ripa P, Ornello R, Degan D, Tiseo C, Stewart J, Pistoia F . Migraine in menopausal women: a systematic review. Int J Womens Health. 2015; 7:773-82. PMC: 4548761. DOI: 10.2147/IJWH.S70073. View

Kelman L . The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007; 27(5):394-402. DOI: 10.1111/j.1468-2982.2007.01303.x. View

Shaver J, Woods N . Sleep and menopause: a narrative review. Menopause. 2015; 22(8):899-915. DOI: 10.1097/GME.0000000000000499. View

10.

Sacco S, Ricci S, Degan D, Carolei A . Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012; 13(3):177-89. PMC: 3311830. DOI: 10.1007/s10194-012-0424-y. View

11.

MacGregor E . Migraine headache in perimenopausal and menopausal women. Curr Pain Headache Rep. 2009; 13(5):399-403. DOI: 10.1007/s11916-009-0065-2. View

12.

Ibrahimi K, van Oosterhout W, van Dorp W, Danser A, Garrelds I, Kushner S . Reduced trigeminovascular cyclicity in patients with menstrually related migraine. Neurology. 2014; 84(2):125-31. DOI: 10.1212/WNL.0000000000001142. View

13.

MacGregor E, Victor T, Hu X, Xiang Q, Puenpatom R, Chen W . Characteristics of menstrual vs nonmenstrual migraine: a post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial. Headache. 2010; 50(4):528-38. DOI: 10.1111/j.1526-4610.2010.01625.x. View

14.

Pavlovic J, Stewart W, Bruce C, Gorman J, Sun H, Buse D . Burden of migraine related to menses: results from the AMPP study. J Headache Pain. 2015; 16:24. PMC: 4406925. DOI: 10.1186/s10194-015-0503-y. View

15.

Martin V, Pavlovic J, Fanning K, Buse D, Reed M, Lipton R . Perimenopause and Menopause Are Associated With High Frequency Headache in Women With Migraine: Results of the American Migraine Prevalence and Prevention Study. Headache. 2016; 56(2):292-305. DOI: 10.1111/head.12763. View

16.

Kravitz H, Schott L, Joffe H, Cyranowski J, Bromberger J . Do anxiety symptoms predict major depressive disorder in midlife women? The Study of Women's Health Across the Nation (SWAN) Mental Health Study (MHS). Psychol Med. 2014; 44(12):2593-602. PMC: 4135380. DOI: 10.1017/S0033291714000075. View

17.

MacGregor A . Effects of oral and transdermal estrogen replacement on migraine. Cephalalgia. 1999; 19(2):124-5. DOI: 10.1046/j.1468-2982.1999.019002124.x. View

18.

Epstein M, HOCKADAY J, Hockaday T . Migraine and reporoductive hormones throughout the menstrual cycle. Lancet. 1975; 1(7906):543-8. DOI: 10.1016/s0140-6736(75)91558-5. View

19.

Loder S, Sheikh H, Loder E . The prevalence, burden, and treatment of severe, frequent, and migraine headaches in US minority populations: statistics from National Survey studies. Headache. 2015; 55(2):214-28. DOI: 10.1111/head.12506. View

20.

Martin V, Wernke S, Mandell K, Zoma W, Bean J, Pinney S . Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache. 2003; 43(4):309-21. DOI: 10.1046/j.1526-4610.2003.03065.x. View